A South Korean research group has reported in a new paper that artificial intelligence and light-based genetic tools can work together to diagnose and stop Parkinson’s-like disease in mice. The work ...
Arnold is looking to catch drug deals in progress now that Oregon's three-and-a-half-year experiment with decriminalization ...
Builders have expressed concern over a slew of labor, environmental, and safety mandates they argue have suppressed competitiveness.
Late-breaking clinical data presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis Across non-active progressive MS (primary progressive and ...
Treatment of Parkinson's and Lewy body patient brain tissue with WTX-607 demonstrated highly specific binding to aggregates within neurons in patients' ...
Far more partisan than the straightforward alerts that typically grace agency websites during shutdowns, the messages are in ...
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced ...
Detailed price information for Bay National Corp (BAYN) from The Globe and Mail including charting and trades.
BlueRock Therapeutics reports positive 36-month results from phase I trial of bemdaneprocel for treating Parkinson’s disease: Berlin, Germany Wednesday, October 8, 2025, 18:00 H ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback